{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:05:13Z","timestamp":1786133113493,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>\n                    Evaluation of GFR, required in the evaluation of living kidney donor candidates, is now receiving increasing emphasis because recent data demonstrate increased risk of kidney disease after donation, including a small increase in the risk of kidney failure. The international guideline development group, Kidney Disease Improving Global Outcomes, recently published a comprehensive set of recommendations for living donor evaluation, with three recommendations regarding GFR. (\n                    <jats:italic toggle=\"yes\">1<\/jats:italic>\n                    ) Donor candidacy is evaluated in light of long-term risk, in which GFR is one of many factors. ESRD is considered a central outcome, and a method for estimating long-term risk of ESRD in donor candidates is described. (\n                    <jats:italic toggle=\"yes\">2<\/jats:italic>\n                    ) Two GFR thresholds are used for decision-making: a high threshold (\u226590 ml\/min per 1.73 m\n                    <jats:sup>2<\/jats:sup>\n                    ) to accept and a low threshold (&lt;60 ml\/min per 1.73 m\n                    <jats:sup>2<\/jats:sup>\n                    ) to decline, with 60\u201389 ml\/min per 1.73 m\n                    <jats:sup>2<\/jats:sup>\n                    as an intermediate range in which the decision to accept or decline is made on the basis of factors in addition to GFR. (\n                    <jats:italic toggle=\"yes\">3<\/jats:italic>\n                    ) GFR is evaluated using several methods available at the transplant center, including estimating equations and clearance measurements. We review the rationale for the guideline recommendations, principles of GFR measurement and estimation, and our suggestions for implementation.\n                  <\/jats:p>","DOI":"10.1681\/asn.2016070790","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T20:25:28Z","timestamp":1489609528000},"page":"1062-1071","source":"Crossref","is-referenced-by-count":42,"title":["GFR Evaluation in Living Kidney Donor Candidates"],"prefix":"10.1681","volume":"28","author":[{"given":"Andrew S.","family":"Levey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Inker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,3,15]]},"reference":[{"key":"B2-20230829","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis.","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"B3-20230829","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2013.460","article-title":"Long-term risks for kidney donors.","volume":"86","author":"Mj\u00f8en","year":"2014","journal-title":"Kidney Int"},{"key":"B4-20230829","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.2013.285141","article-title":"Risk of end-stage renal disease following live kidney donation.","volume":"311","author":"Muzaale","year":"2014","journal-title":"JAMA"},{"key":"B6-20230829","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"B7-20230829","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1510491","article-title":"Kidney-failure risk projection for the living kidney-donor candidate.","volume":"374","author":"Grams","year":"2016","journal-title":"N Engl J Med"},{"key":"B8-20230829","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/j.ajkd.2015.01.019","article-title":"A prospective controlled study of living kidney donors: Three-year follow-up.","volume":"66","author":"Kasiske","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B9-20230829","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/sj.ki.5001819","article-title":"Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression.","volume":"70","author":"Garg","year":"2006","journal-title":"Kidney Int"},{"key":"B10-20230829","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1681\/ASN.2015091018","article-title":"Renal function profile in white kidney donors: The first 4 decades.","volume":"27","author":"Ibrahim","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B11-20230829","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa0804883","article-title":"Long-term consequences of kidney donation.","volume":"360","author":"Ibrahim","year":"2009","journal-title":"N Engl J Med"},{"key":"B12-20230829","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1408932","article-title":"Gestational hypertension and preeclampsia in living kidney donors.","volume":"372","author":"Garg","year":"2015","journal-title":"N Engl J Med"},{"key":"B13-20230829","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7326\/0003-4819-145-3-200608010-00006","article-title":"Meta-analysis: Risk for hypertension in living kidney donors.","volume":"145","author":"Boudville","year":"2006","journal-title":"Ann Intern Med"},{"key":"B14-20230829","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/j.ajkd.2015.01.017","article-title":"Gout after living kidney donation: A matched cohort study.","volume":"65","author":"Lam","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B15-20230829","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.ajkd.2013.01.027","article-title":"A prospective controlled study of kidney donors: Baseline and 6-month follow-up.","volume":"62","author":"Kasiske","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B16-20230829","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJMe1513891","article-title":"The risks of living kidney donation.","volume":"374","author":"Steiner","year":"2016","journal-title":"N Engl J Med"},{"key":"B17-20230829","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/jama.2013.285142","article-title":"Understanding rare adverse outcomes following living kidney donation.","volume":"311","author":"Gill","year":"2014","journal-title":"JAMA"},{"key":"B18-20230829","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/ajt.12804","article-title":"Quantifying risk of kidney donation: The truth is not out there (yet).","volume":"14","author":"Kaplan","year":"2014","journal-title":"Am J Transplant"},{"key":"B20-20230829","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.2015.6753","article-title":"Chronic kidney disease in older people.","volume":"314","author":"Levey","year":"2015","journal-title":"JAMA"},{"key":"B21-20230829","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jama.2015.6731","article-title":"An age-calibrated classification of chronic kidney disease.","volume":"314","author":"Glassock","year":"2015","journal-title":"JAMA"},{"key":"B22-20230829","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jama.2015.16002","article-title":"Managing Chronic Kidney Disease in Older People - Reply.","volume":"315","author":"Levey","year":"2016","journal-title":"JAMA"},{"key":"B23-20230829","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jama.2015.15999","article-title":"Managing chronic kidney disease in older people--Reply.","volume":"315","author":"Glassock","year":"2016","journal-title":"JAMA"},{"key":"B24-20230829","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.ajkd.2011.06.012","article-title":"Level and determinants of kidney function in a South Asian population in Pakistan.","volume":"58","author":"Jafar","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"B25-20230829","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2009.11","article-title":"Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors.","volume":"75","author":"Poggio","year":"2009","journal-title":"Kidney Int"},{"key":"B26-20230829","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00006231-200501000-00010","article-title":"Reference data for 51Cr-EDTA measurements of the glomerular filtration rate derived from live kidney donors.","volume":"26","author":"Grewal","year":"2005","journal-title":"Nucl Med Commun"},{"key":"B27-20230829","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1681\/ASN.2009121248","article-title":"The clinical importance of nephron mass.","volume":"21","author":"Luyckx","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B28-20230829","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1681\/ASN.2016020154","article-title":"The substantial loss of nephrons in healthy human kidneys with aging.","volume":"28","author":"Denic","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B30-20230829","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/j.ajkd.2014.04.010","article-title":"Measuring GFR: A systematic review.","volume":"64","author":"Soveri","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B31-20230829","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1053\/j.ajkd.2013.12.006","article-title":"GFR estimation: From physiology to public health.","volume":"63","author":"Levey","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B32-20230829","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/ndt\/gft509","article-title":"Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test.","volume":"29","author":"Fan","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B33-20230829","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C.","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"B34-20230829","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/00007890-200011150-00016","article-title":"Low absolute glomerular filtration rate in the living kidney donor: A risk factor for graft loss.","volume":"70","author":"Nord\u00e9n","year":"2000","journal-title":"Transplantation"},{"key":"B35-20230829","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s40472-014-0043-4","article-title":"Evaluation of kidney function and structure in potential living kidney donors: Implications for the donor and recipient.","volume":"2","author":"Zaky","year":"2015","journal-title":"Curr Transpl Rep"},{"key":"B36-20230829","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1600-6143.2007.01932.x","article-title":"The medical evaluation of living kidney donors: A survey of US transplant centers.","volume":"7","author":"Mandelbrot","year":"2007","journal-title":"Am J Transplant"},{"key":"B37-20230829","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/ajt.13540","article-title":"Estimated GFR for living kidney donor evaluation.","volume":"16","author":"Huang","year":"2016","journal-title":"Am J Transplant"},{"key":"B39-20230829","article-title":"Estimated or measured GFR in living kidney donors work-up? [published online ahead of print June 6, 2016].","author":"Gaillard","journal-title":"Am J Transplant"},{"key":"B41-20230829","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1681\/ASN.2014080771","article-title":"A lifetime of allograft function with kidneys from older donors.","volume":"26","author":"Rose","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B42-20230829","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1681\/ASN.2013070784","article-title":"New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes.","volume":"25","author":"Israni","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B43-20230829","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.suc.2013.08.007","article-title":"The kidney allocation system.","volume":"93","author":"Friedewald","year":"2013","journal-title":"Surg Clin North Am"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201704000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:28:52Z","timestamp":1786130932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201704000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,15]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2016070790","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,15]]}}}